Federal Supply Schedule 36F79721D0183
Award Date
7/1/21
Last Date to Order
6/30/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Akebia Therapeutics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Pharmaessentia USA Corp, a foreign-owned for-profit organization. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a ceiling value of $6,000,000.00 and a period of performance from June 1, 2022 to May 31,...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
This is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12) to Ajanta Pharma USA Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance from December 2, 2024 to May 31, 2025. As a Federal Supply Schedule contract, this vehicle allows VISN 12, which is a civilian federal agency, to procure pharmaceutical and...
This Federal Supply Schedule contract award, with a ceiling value of $48,300,000.00, was made by the Veterans Integrated Service Network 12 (VISN 12) to Tersera Therapeutics LLC, a for-profit limited liability company manufacturer of goods. The contract, which has a period of performance ending on March 14, 2029, is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products under the 65 I B Federal Supply Schedule category. As a multiple award Federal Supply Schedule contract,...
The Federal Supply Schedule contract (ID: 36F79723D0238) was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Mylan Institutional LLC, a for-profit limited liability company manufacturer of goods. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products, with a ceiling value of $94,000,000 and a period of performance from September 29, 2023, to September 28, 2028. The contract was awarded without any set-asides and on...
The provided information details a Federal Supply Schedule (FSS) contract award to Aveo Pharmaceuticals, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The $45,580,967.00 ceiling value contract has an ultimate completion date of October 14, 2026. The contract aims to procure pharmaceutical and hematology-related products to support the VA's healthcare operations. As an FSS contract, it allows for the placement of task...